Lung Cancer
Carcinoma of Upper Lobe of Right Lung
Male, 62 years
Patient Internal ID: 102389711
ICD-10 code
C34.1 Malignant Neoplasm of Upper Lobe, Bronchus or Lung
Diagnosis (Incl. Metastases/Stage) and Year
December 2010
Carcinoma of Upper Lobe of Right Lung pT1a N0M0R0 G2 I st.
May 2020 disease progression.
Pleomorphic Carcinoma of the Lung with Partial Neuroendocrine Differentiation with Metastasis in both Lungs pT1aNxM1.
Previous Treatment
Surgery (Segmentectomy), Target Therapy (Erlotinib), Radiation Therapy, Surgery (Segmentectomy – 2nd), Chemotherapy (Carboplatin, Paclitaxel), Chemotherapy (Gemcitabine).
Prognosis and Survival Expectation
The prognosis remains poor, with a median survival of ~1 year from diagnosis.
Treatment Provided
Autologous DCV (10 doses) and CIK (4 doses) over a period of 14 months. Additionally, the patient received Umbilical Cord Blood Derived NK cells (8 doses).
Patient Survival/Condition and Year
Date of Review: 15/10/2023
After the disease progression, the patient survived for 3 years. It can be concluded that Immunotherapy, alongside Surgery, Chemotherapies and Radiation Therapy, has extended the patient’s survival by around 2 years compared with median survival.
